Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127033521 | 12703352 | 1 | I | 20160825 | 20160831 | 20160831 | EXP | GB-JNJFOC-20160822334 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160831 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127033521 | 12703352 | 1 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | N | UNKNOWN | 21976 | TABLETS | ||||||||
127033521 | 12703352 | 2 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
127033521 | 12703352 | 3 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
127033521 | 12703352 | 4 | SS | EMTRIVA | EMTRICITABINE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127033521 | 12703352 | 1 | HIV infection |
127033521 | 12703352 | 2 | Product used for unknown indication |
127033521 | 12703352 | 3 | Product used for unknown indication |
127033521 | 12703352 | 4 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127033521 | 12703352 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127033521 | 12703352 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |